Skip to main content
CAMP logo

Camp4 Therapeutics Corporation

CAMPNASDAQHealthcareBiotechnology

$4.33Today:- (-)1Y +4.84%

As of Nov 10, 2026 close

Market cap
$341.83M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.90$7.75
Volume (live)
-
Avg. volume (3M)
225.95K

Camp4 Therapeutics (CAMP) Stock Price & Financial Analysis

Camp4 Therapeutics Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$4.25 - $4.63
52-Week High$7.75
52-Week Low$2.90
Open$4.63
Volume (last close)109.02K
Average Volume (3M)225.95K
Earnings & Profitability
Revenue (TTM)5.32M
Net Income (TTM)-107.24M
Free Cash Flow (TTM)-26.41M
EPS (TTM)−$2.20
Profit Margin-2015.86%
Operating Margin-993.95%
Return on Equity (ROE)-100.14%
Debt to Equity0.02
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Size & Valuation
Market Cap341.83M
Shares Outstanding78.95M
Price to Sales (P/S)64.25
Price to Book (P/B)3.19
EV/EBITDA-2.22
Technical Indicators
50-Day MA$3.86
200-Day MA$4.20
1-Year Change+4.84%

Source: Market prices and company fundamentals. Data as of Nov 10, 2026. Data sources and methodology

Compare CAMP with other stocks

Camp4 Therapeutics at a Glance

As of the Nov 10, 2026 close, Camp4 Therapeutics (CAMP) has a market capitalization of $341.83M. The stock trades at 64.3× sales. Over the trailing twelve months it lost $107.24M on revenue of $5.32M and burned $26.41M of free cash flow. Revenue grew 39.9% year over year.

As of its latest reported balance sheet, it holds $124.52M in cash and securities against $2.37M of debt, a net cash position of $122.15M.

Camp4 Therapeutics does not currently pay a dividend.

The share price is up 4.8% over the past year. At $4.33 (the Nov 10, 2026 close) it sits within its 52-week range of $2.90 to $7.75, above its 200-day moving average of $4.20.

Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $9.00, 107.9% above the Nov 10, 2026 close.

Frequently Asked Questions About Camp4 Therapeutics

What is the current stock price for CAMP?

As of the Nov 10, 2026 close, CAMP stock trades at $4.33. The 52-week range is $2.90–$7.75, with a day range of $4.25–$4.63.

What is the P/E ratio for CAMP?

Camp4 Therapeutics has no trailing P/E ratio because it reported a net loss over the last twelve months.

Does CAMP pay dividends?

Camp4 Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for CAMP?

Based on ratings from 7 professional analysts over the last 90 days, the consensus for CAMP is Buy. The average 12-month price target is $9.00, a 107.9% upside from the Nov 10, 2026 close of $4.33.

What is the market cap of CAMP?

As of the Nov 10, 2026 close, Camp4 Therapeutics's market capitalization is $341.8M, classifying it as a small-cap company. Camp4 Therapeutics operates in the Healthcare sector within the Biotechnology industry.